Alkermes (ALKS) EPS (Diluted) (QoQ) (2010 - 2026)
Alkermes (ALKS) EPS (Diluted) (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 100.75% |
| Mar 31, 2026 | -236.76% |
| Dec 31, 2024 | 329.86% |
| Sep 30, 2024 | 87.42% |
| Jun 30, 2024 | -57.35% |
| Mar 31, 2024 | 93.96% |
| Dec 31, 2023 | 8.74% |
| Sep 30, 2023 | -7.55% |
| Jun 30, 2023 | -10.86% |
| Mar 31, 2023 | -141.25% |
| Dec 31, 2022 | 237.73% |
| Sep 30, 2022 | -111.71% |
| Jun 30, 2022 | 16.76% |
| Mar 31, 2022 | -128.35% |
| Dec 31, 2021 | 534.12% |
| Sep 30, 2021 | -1,345.07% |
| Jun 30, 2021 | 110.21% |
| Mar 31, 2021 | 47.43% |
| Dec 31, 2020 | -31,740.82% |
| Sep 30, 2020 | 99.54% |